Alternativen zu Lactic Acid (topical)

Barrier-repair skincare applied to the skin — ceramide-containing moisturizers, NOT (in this context) oral ceramide supplements. Ceramides are the lipids that, with cholesterol and fatty acids, form the skin's water-proofing 'mortar.' These lipids are genuinely depleted in dry, aging, and atopic (eczema-prone) skin, so replacing them topically has a sound rationale. The honest framing: ceramide creams reliably lower water loss, raise hydration, and reduce eczema flares — but head-to-head trials show no consistent advantage over a good basic moisturizer (plain petrolatum, or a hyaluronic-acid foam), so most of the benefit is the moisturizing itself, with the ceramide a plausible-but-unproven upgrade. They are very well tolerated. These are skin-barrier/appearance outcomes, not health outcomes.

A topical humectant applied to the skin (serums/creams) for hydration and short-term fine-line smoothing — a cosmetic, NOT (in this context) an oral supplement, injectable filler, or joint injection. Hyaluronic acid is a water-binding sugar naturally abundant in skin. The honest framing: topical HA reliably improves surface hydration and modestly improves elasticity and fine-line appearance in controlled trials — but the benefit is largely a surface plumping/hydration effect. Standard high-molecular-weight HA penetrates poorly and stays in the outermost layer; only low-molecular-weight or fragment HA meaningfully penetrates, so real-world effect is molecular-weight- and formulation-dependent. It is very well tolerated. These are cosmetic appearance outcomes, not health outcomes, and topical HA is not a dermal filler.

A topical cosmetic form of vitamin B3 — a leave-on skincare active applied to the skin, NOT (in this context) an ingested supplement. Niacinamide (nicotinamide) is one of the better-evidenced cosmetic actives: short, double-blind, split-face trials — many run or funded by Procter & Gamble — show real but modest improvements in hyperpigmentation, fine lines, sallowness, sebum, and the skin barrier at roughly 2-5%. It is mechanistically plausible (it boosts ceramide/barrier-lipid synthesis and reduces transfer of pigment to skin cells) and consistently well tolerated. The honest framing: it is generally an ADJUVANT rather than a first-line active — in head-to-head pigmentation trials hydroquinone still edges it out — and most trials are small and industry-linked. These are cosmetic appearance outcomes, not health outcomes. (Separately, ORAL nicotinamide has its own, unrelated evidence for reducing non-melanoma skin cancers — that is a different, ingested use and not what this topical entry covers.)

A topical provitamin B5 applied to the skin for hydration, barrier repair, and soothing — a cosmetic/derm ingredient, not (in this context) an ingested supplement. Panthenol converts in skin to pantothenic acid (vitamin B5), a building block of coenzyme A, and acts as a humectant. The honest framing: it has reasonably consistent controlled-trial evidence — it lowers transepidermal water loss, raises hydration, speeds barrier repair after irritation, and accelerates early-phase superficial wound healing — with a plausible mechanism. Caveats: trials are small, many test multi-ingredient or branded formulations (often manufacturer-run), and head-to-head it isn't always best (outperformed by ectoin in radiodermatitis; no clear advantage over plain ointment in diaper rash). A well-tolerated, genuinely useful barrier/soothing ingredient.

Hydrolyzed peptides that rebuild skin elasticity, reduce joint pain, and strengthen bone density — results build over 8-12 weeks.

Type I collagen from fish with smaller peptide size for superior absorption — proven benefits for skin hydration and wrinkle reduction.

Holds 1,000x its weight in water. Most strong evidence is for injectable/intra-articular HA in knee osteoarthritis; oral supplementation shows small, inconsistent benefits for skin and joints.

An algae-derived carotenoid antioxidant. The honest verdict: meta-analyses show small skin-aging and oxidative-stress-marker benefits, but trials are few, small, often industry-funded, and outcomes are biomarker- or cosmetic-level rather than hard clinical endpoints.